Coupled to this, serum levels of tumor necrosis factor-α (TNF-α) and macrophage inflammatory protein-1α (MIP-1α), cytokines being regulated by TLR signaling [8, 9], were significantly increased in CLL patients following SPC2996 treatment [7]. The gene discussed is TNF; the disease is B-cell chronic lymphocytic leukemia.